Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reported at the ASCO congress.

In May 2024, Google DeepMind released AlphaFold 3, a game changing protein folding model that predicts with 50% better ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

SKOPJE – A bottleneck in health-care services is causing dangerous delays in the diagnosis and treatment of breast cancer in ...

A calculated flaw in perfection. New research suggests that Renaissance master artist Michelangelo Buonarroti had etched a ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...

Yale study reveals cultural influences in breast cancer surgery decisions, focusing on challenges faced by women of color post-mastectomy.

Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer and urge viewers to consider genetic testing if they're high risk — a step ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

Mitochondria have long been known as the tiny organelles that act as the battery packs inside our cells while also serving as internal sensors and communicators.